Conditions + Treatments

Hemangiopericytoma in Children

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact Dana-Farber/ Boston Children's

Overview

Hemangiopericytoma is a rare tumor that grows in the body’s soft tissue, which includes fat, muscles, tendons, nerves, blood vessels and other fibrous tissue.

  • In a baby, this condition is called "infantile myofibromatosis," and the tumors typically go away on their own.
  • In adolescence, the tumor can be benign or malignant; it’s often found in bones, but can spread to the teenager’s lungs.
  • In the United States, about 900 children and adolescents are diagnosed with soft-tissue tumors each year.

The latest research from Dana-Farber/Children's Hospital Cancer Center

Dana-Farber/Children's Hospital Cancer Center researchers are conducting numerous research studies that will help clinicians better understand and treat soft-tissue sarcomas. Innovative types of treatment currently being studied include:

  • Angiogenesis inhibitors — substances that may be able to prevent the growth of tumors by blocking the formation of new blood vessels that feed the tumors.
  • Biological therapies — a wide range of substances that may be able to involve the body's own immune system to fight cancer or lessen harmful side effects of some treatments.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close